Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone disease after kidney transplantation.

Anna L Zisman1, Stuart M Sprague

  • 1Division of Nephrology and Hypertension, Evanston Northwestern Healthcare, Northwestern University Feinberg School of Medicine, Evanston, IL 60201, USA.

Advances in Chronic Kidney Disease
|January 18, 2006
PubMed
Summary

Kidney transplant success is improving, but bone and mineral disease are common complications. These disorders are nearly universal in patients with chronic kidney disease awaiting transplantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Nephrology Consultation and Acute Kidney Injury in Hospitalized Patients: A Randomized Clinical Trial.

JAMA network open·2026
Same author

Patient Perceptions of Dietary Supplement Use and Kidney Stone Disease.

Nutrients·2026
Same author

Shaping an Early Nephrology Fellowship Curriculum: Results from the American Society of Nephrology Fellow Survey.

Kidney360·2026
Same author

Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.

Kidney360·2026
Same author

Managing Dysregulated Vitamin D Metabolism in CKD: Time to Update Conventional Wisdom?

Kidney360·2025
Same author

A Pan-Inhibitor of Phosphate Transporters AP306 in Hemodialysis Patients.

Kidney international reports·2025

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Endocrinology

Background:

  • Immunosuppressive therapies have significantly improved kidney transplant allograft survival.
  • Increased success in transplantation highlights the importance of managing subsequent complications.
  • Bone and mineral disease are recognized complications following kidney transplantation.

Purpose of the Study:

  • To review the pathophysiology and clinical significance of bone and mineral disease in kidney transplant recipients.
  • To understand the prevalence and contributing factors of mineral metabolism disorders in patients with chronic kidney disease awaiting transplantation.

Main Methods:

  • Literature review of studies on immunosuppressive therapy, kidney transplantation, and bone/mineral disease.
  • Analysis of pathophysiologic mechanisms contributing to renal osteodystrophy in chronic kidney disease.

Related Experiment Videos

  • Synthesis of current understanding regarding mineral metabolism disorders in pre- and post-transplant kidney patients.

    • Main Results:

    • Advances in immunosuppression enhance kidney allograft survival.
    • Bone and mineral disease are prevalent complications in kidney transplant recipients.
    • Disorders of mineral metabolism and renal osteodystrophy are nearly universal in patients with chronic kidney disease awaiting transplantation.

    Conclusions:

    • Effective immunosuppression necessitates a comprehensive approach to managing post-transplant complications.
    • Understanding the diverse pathophysiologic mechanisms is crucial for addressing mineral and bone disease in kidney disease patients.
    • Early recognition and management of bone and mineral disorders are essential for long-term patient outcomes in kidney transplantation.